Katie Price CBD cancer claims are now under scrutiny after the media personality faced backlash for promoting a cannabidiol product while suggesting it could cure cancer. The 47-year-old model and television personality has been referred to Liverpool Trading Standards following complaints over her social media posts promoting Supreme CBD.
The controversy began in April 2025 when Katie shared a post on X in support of former Olympic boxer Anthony Fowler. Fowler claimed his two-year-old daughter’s tumour was “healed” after refusing chemotherapy and using Supreme CBD. Katie’s posts, including Instagram promotions featuring the product and her endorsement, led to official complaints submitted to the Advertising Standards Authority (ASA).
According to the ASA, the situation escalated beyond their immediate powers because Katie Price continued to publicly discuss the product as a paid ambassador. The ASA has confirmed that Supreme CBD has been referred to Trading Standards, which acts as the legal enforcement body for potentially misleading health claims.
An ASA spokesperson explained: “We have received a small number of complaints about Supreme CBD and Katie Price’s ads. Trading Standards now acts as our legal backstop. Our compliance team continues to assess any further action, including engagement with relevant platforms if necessary.”
Katie Price’s April 2025 post described a conversation with Anthony Fowler and his partner, stating: “Very serious chat with Serena Stregapede and Anthony Fowler about their two-year-old daughter who had a tumour in her leg, they refused hospital treatment and healed her themselves which is amazing. They were telling me all about Supreme CBD and how it works for fibromyalgia, arthritis, anxiety/depression, any aches/pains or insomnia.” The post included a checkout code for the product.
The post received widespread criticism on social media. Users condemned the claims, with comments including: “It does not cure cancer ffs!” and “It is irresponsible to suggest CBD would shrink a tumour like that. CBD used responsibly and alongside other medicines can have pain relieving and calming effects, but no reputable supplier would allow this type of endorsement. It is illegal.”
This is not the first instance of Katie Price facing scrutiny over product endorsements. In April 2024, she was required to remove an Instagram post promoting The Skinny Food Co. In that promotion, she highlighted a coffee syrup and low-calorie porridge, claiming weight loss benefits. The ASA found the post lacked clear advertising disclosure, promoted a diet under 800 calories per day, and included unauthorised health claims.
The ongoing investigation highlights the regulatory risks of promoting health supplements with unverified claims. Public authorities such as the ASA and Trading Standards aim to prevent misleading marketing that could pose risks to vulnerable audiences, particularly in cases involving children or serious illnesses.
Katie Price’s case underscores the growing scrutiny on social media endorsements and the importance of responsible communication when discussing health-related products.
